Cite
MLA Citation
S Gadgeel et al.. “Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study.” Annals of oncology, vol. 29, 2018, pp. 2214–2222. http://access.bl.uk/ark:/81055/vdc_100095507184.0x000036